0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query qyresearch china adalimumab industry report 2015.Your search for "" gave back 1533064 results.
The global Behcet Disease Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR)...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Systemic Idiopathic Juvenile Arthritis Treatment Market The global Systemic Idiopathic Juvenile Arthritis...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Highlights The global Polyarticular Juvenile Idiopathic Arthritis Drug market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The global Ulcerative Colitis Immunology Drugs market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Polyarticular Juvenile Idiopathic Arthritis Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Amgen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Amgen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
November 2022
Price: USD 175.00
AbbVie Inc - Strategy, SWOT and Corporate Finance Report Summary AbbVie Inc - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
February 2022
Price: USD 175.00
AbbVie Inc. - Strategy, SWOT and Corporate Finance Report Summary AbbVie Inc. - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
November 2022
Price: USD 175.00
Highlights The global Tumor Necrosis Factor Inhibitors Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
November 2019
Price: USD 2,000.00
Psoriatic Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's...
Catalog:
Global Markets Direct
October 2022
Price: USD 2,000.00
The global Tumor Necrosis Factor Inhibitors Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Pipeline Review, H1 2019 Summary According to the recently published report '...
Catalog:
Global Markets Direct
March 2019
Price: USD 3,500.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Tumor Necrosis Factor (TNF) Inhibitors market will...
Catalog:
Arsta
January 2023
Price: USD 3,360.00
TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and...
Catalog:
LPI
February 2023
Price: USD 3,660.00
